Hydroxytyrosol also significantly counteracted the expression of inflammation-related microRNAs, reduced the production of ROS, and prevented the activation of the NF-κB pathway, which is known to exacerbate inflammatory responses and insulin resistance, see Figure 3. The gene discussed is NFKB1; the disease is Insulin resistance.